Tourmaline Bio Ownership | Who Owns Tourmaline Bio?

Tourmaline Bio Ownership Summary

Tourmaline Bio is owned by 88.73% institutional investors, 22.62% insiders.

TRML Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Tourmaline Bio	88.73%	22.62%	-11.34%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	102	10.87%	22,862,128	8.70%	88	1.33%	62	37.78%	22	-18.52%
Sep 30, 2024	92	6.98%	21,032,430	-0.59%	81	1.21%	45	-18.18%	27	68.75%
Jun 30, 2024	86	-18.10%	21,157,029	2.91%	82	1.13%	55	-30.38%	16	45.45%
Mar 31, 2024	105	94.44%	20,559,534	58.00%	85	1.29%	79	46.30%	11	-
Dec 31, 2023	54	-	13,012,529	-	81	-	54	-	-	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 21, 2024	Kulkarni Sandeep Chidambar	CEO	Buy	$26.42K
Aug 16, 2024	Kulkarni Sandeep Chidambar	CEO	Buy	$72.00K
Jan 29, 2024	MCDADE MARK	-	Buy	$3.25M

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q3	2	-
2024 Q2	-	-
2024 Q1	1	-

TRML Ownership FAQ

Who Owns Tourmaline Bio?

Tourmaline Bio shareholders are primarily institutional investors at 88.73%, followed by 22.62% insiders and -11.35% retail investors. The average institutional ownership in Tourmaline Bio's industry, Biotech Stocks , is 68.48%, which Tourmaline Bio exceeds.

Does Blackrock own Tourmaline Bio?

BlackRock is not among the top 10 institutional shareholders of Tourmaline Bio.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools